EUVIMEDEUVIMED entdecken
Crossref

Combined treatment of HPV-positive HNSCC cells with Xevinapant, Tuvusertib and ionizing radiation

Julius Röhrle, Henrike Zech, Fruszina Gatzemeier, Sabrina Christiansen, Nanik Wahrhausen, Cordula Petersen, Christian Betz, Kai Rothkamm, Thorsten Rieckmann

Laryngo-Rhino-Otologie · 01.05.2024 · 103 (S 02 S 02) · S235-S236

DOI: 10.1055/s-0044-1784772 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laryngo-Rhino-Otologie, erschienen am 01.05.2024. Verfasst von Julius Röhrle und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Combined treatment of HPV-positive HNSCC cells with Xevinapant, Tuvusertib and ionizing radiation

Zitieren

APA

Röhrle, J., Zech, H., Gatzemeier, F., Christiansen, S., Wahrhausen, N., Petersen, C., Betz, C., Rothkamm, K., & Rieckmann, T. (2024). Combined treatment of HPV-positive HNSCC cells with Xevinapant, Tuvusertib and ionizing radiation. Laryngo-Rhino-Otologie, 103(S 02 S 02), S235-S236. https://doi.org/10.1055/s-0044-1784772

Vancouver

Röhrle J, Zech H, Gatzemeier F, Christiansen S, Wahrhausen N, Petersen C, et al. Combined treatment of HPV-positive HNSCC cells with Xevinapant, Tuvusertib and ionizing radiation. Laryngo-Rhino-Otologie. 2024;103(S 02 S 02):S235-S236. doi:10.1055/s-0044-1784772

BibTeX
@article{Rhrle2024,
  author = {Röhrle, Julius and Zech, Henrike and Gatzemeier, Fruszina and Christiansen, Sabrina and Wahrhausen, Nanik and Petersen, Cordula and Betz, Christian and Rothkamm, Kai and Rieckmann, Thorsten},
  title = {Combined treatment of HPV-positive HNSCC cells with Xevinapant, Tuvusertib and ionizing radiation},
  journal = {Laryngo-Rhino-Otologie},
  year = {2024},
  volume = {103},
  number = {S 02 S 02},
  pages = {S235--S236},
  doi = {10.1055/s-0044-1784772}
}
Kostenlos starten →